Direkt zum Inhalt
Merck

Serum squalene in postmenopausal women without and with coronary artery disease.

Atherosclerosis (1999-09-16)
R A Rajaratnam, H Gylling, T A Miettinen
ZUSAMMENFASSUNG

Squalene, found in earlier studies in human atherosclerotic plaques, was measured in the serum of postmenopausal women with coronary artery disease (CAD) (n = 25) and randomly chosen age-matched healthy controls (n = 30). The squalene concentrations of the whole population ranged from 37.5 to 115.5 microg/dl, and were higher in serum of the CAD than healthy women (91.4+/-2.6 versus 65.2+/-2.6 microg/dl, P = 0.000), a finding observed also in relation to cholesterol (43.8+/-1.8 versus 32.9+/-1.1 10(2)x mmol/mol of cholesterol, P = 0.000). The squalene concentration was also increased in chylomicrons, VLDL and d>1.006 g/ml lipoproteins, and the proportions to cholesterol in VLDL and d>1.006 g/ml lipoproteins. The respective squalene and cholesterol concentrations were related to each other in serum, VLDL and d>1.006 g/ml lipoproteins (r = 0.52, 0.85 and 0.55, respectively), whereas the correlation with triglycerides was seen only in VLDL (r = 0.84) over the whole population. Besides enhanced intestinal secretion, it remains to be shown whether higher serum squalene in postmenopausal coronary women is due to increased cholesterol synthesis or a defect in squalene conversion to lanosterol.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Progesteron, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Prostaglandin E2, synthetic, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Progesteron, ≥99%
Sigma-Aldrich
Estron, ≥99%
Sigma-Aldrich
Progesteron, meets USP testing specifications
Sigma-Aldrich
Prostaglandin E2, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Progesteron, γ-irradiated, BioXtra, suitable for cell culture
Supelco
Progesteron, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Prostaglandin E2, ≥93% (HPLC), synthetic
Supelco
Androstenedione solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Progesterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Estrone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
4-Androsten-3,17-dion, VETRANAL®, analytical standard
Supelco
Progesteron, VETRANAL®, analytical standard
Dinoproston, European Pharmacopoeia (EP) Reference Standard
Estron, European Pharmacopoeia (EP) Reference Standard